Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

Editas Medicine (EDIT) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.71 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -20.63%. A quarter ago, it was expected that this genome editing company would post a loss of $0.52 per share when it actually produced a loss of $0.23, delivering a surprise of 55.77%.Over the last four quarters, the comp ...